Embodying the Vision Award - Patient Study
caBIG™ 2007 Recognition Award Winners
Embodying the Vision Award winners have helped to achieve the caBIG? vision through ongoing activities and multiple program accomplishments that are in alignment with the true spirit and vision of caBIG™. Awardees have been instrumental in fostering collaboration across workspaces, projects, and institutions.
Patient Study Calendar Development Team: Cal Collins, Tom Hickerson, Shai Sachs, Jaron Sampson, Yufang Wang, Jun Xu (Akaza Research); Dong Fu, Moses Hohman, Warren Kibbe, Eric Odulio, John Osborne, Rhett Sutphin, Renee Webb, Sean Whitaker, Andrew Winter, Julie Zhu (Northwestern University); Ram Chilukuri, Vinay Kumar, Edmond Mulaire, Joshua Phillips, Padmaja Vedula (SemanticBits, LLC.)
Clinical Trial Management Systems Workspace
In recognition of excellence for the successful application of caBIG principles and best practices for the Patient Study Calendar Module, The Patient Study Calendar Development Team has been awarded an Embodying the Vision Award.
The team used caBIG principles and best practices to build a CTMS Silver Level-compliant Patient Study Calendar Module. The team provided four complete releases in six months, while working with the Study Calendar SIG, a group of dedicated testers, and the CTMS workspace. Center and their partners are the developers of RProteomics, which provides a user interface and services for analyzing proteomics mass spectometry data; the Cancer Translational Research Informatics Platform (caTRIP), a project that connects the caTISSUE Core, the Clinical Annotation Engine (CAE), Tumor Registry, and caIntegrator SNP projects to provide a mechanism for translational research; and the Cancer Central Clinical Patient Registry (C3PR), a system for registering patients to clinical trial protocols, an important integration point in the caBIG CTMS suite of applications. Duke CCC and their partners have also created the testing infrastructure for the caGrid Project, with a special focus on workflows, and are adopters of the caTISSUE Core and the Cancer Central Clinical Database (C3D).